Skip to main content

Advertisement

SpringerLink
Log in

Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patients with Clear-Cell Carcinoma

  • ONCOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The concentration of kidney injury molecule-1 (KIM-1) was measured in blood plasma of 99 patients with clear-cell carcinoma and 14 patients with benign renal tumors using a Human Serum TIM-1/KIM-1/HAVCR Quantikine ELISA kit. The control group consisted of 15 healthy male and 14 healthy female subjects. KIM-1 levels in blood plasma of patients with cancer or benign renal tumors were significantly higher than in the control (p<0.00001 and p<0.01, respectively). In patients with benign tumors, this parameter was significantly lower than in patients with cancer (p<0.0001). KIM-1 level significantly increased with disease stage (p<0.0001), and even in stage I cancer, it was higher than in the control group (p<0.0001) or in patients with benign tumors (p<0.01). The best sensitivity/specificity ratio for stage I renal cancer detection (81 and 83% respectively) was achieved at cut-off level 77 pg/ml, the sensitivity of detection of for stages II-IV being 97%. Plasma level of KIM-1 increased with increasing the size and area of the primary tumor (T). This parameter was higher in patients with metastasis in regional lymph nodes irrespective of their number (N1 or N2) in comparison with patients without regional metastasis (N0). It is also higher in patients with distant metastasis (M+). In patients with grade III-IV cancer, KIM-1 level was 7-fold higher than in patients with grade I-II tumor (p<0.0001). Thus, KIM-1 can be regarded as a highly sensitive marker for early detection of clear-cell carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abassi Z, Shalabi A, Sohotnik R, Nativ O, Awad H, Bishara B, Frajewicki V, Sukhotnik I, Abbasi A, Nativ O. Urinary NGAL and KIM-1: biomarkers for assessment of acute ischemic kidney injury following nephron sparing surgery. J. Urol. 2013;189(4):1559-1566.

    Article  CAS  PubMed  Google Scholar 

  2. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J. Biol. Chem. 2002;277(42):39,739-39,748.

    Article  CAS  Google Scholar 

  3. Carvalho Pedrosa D, Macedo de Oliveira Neves F, Cavalcante Meneses G, Pinheiro Gomes Wirtzbiki G, da Costa Moraes CA, Costa Martins AM, Braga Libório A. Urinary KIM-1 in children undergoing nephrotoxic antineoplastic treatment: a prospective cohort study. Pediatr. Nephrol. 2015;30(12):2207-2213.

  4. Cuadros T, Trilla E, Sarró E, Vilà MR, Vilardell J, de Torres I, Salcedo M, López-Hellin J, Sánchez A, Ramón y Cajal S, Itarte E, Morote J, Meseguer A. HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome. Cancer Res. 2014;74(5):1416-1428.

    Article  CAS  PubMed  Google Scholar 

  5. Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Bonventre JV, Sabbisetti V, Waikar SS, Mifflin TE, Zhang X, Xie D, Hsu CY, Feldman HI, Coresh J, Vasan RS, Kimmel PL, Liu KD; Chronic Kidney Disease Biomarkers Consortium Investigators. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia. 2015;58(1):188-198.

  6. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002; 62(1):237-244.

    Article  CAS  PubMed  Google Scholar 

  7. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 2008;118(5):1657-1668.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Maeda A, Ando H, Ura T, Muro K, Aoki M, Saito K, Kondo E, Takahashi S, Ito Y, Mizuno Y, Fujimura A. Differences in urinary renal failure biomarkers in cancer patients initially treated with cisplatin. Anticancer Res. 2017;37(9):5235-5239.

    CAS  PubMed  Google Scholar 

  9. McWilliam SJ, Antoine DJ, Sabbisetti V, Pearce RE, Jorgensen AL, Lin Y, Leeder JS, Bonventre JV, Smyth RL, Pirmohamed M. Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children. Biomark. Med. 2014;8(10):1189-1197.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Morrissey JJ, London AN, Lambert MC, Kharasch ED. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma. Am. J. Nephrol. 2011;34(5):391-398.

    Article  CAS  PubMed  Google Scholar 

  11. Sabbisetti VS, Waikar SS, Antoine DJ, Smiles A, Wang C, Ravisankar A, Ito K, Sharma S, Ramadesikan S, Lee M, Briskin R, De Jager PL, Ngo TT, Radlinski M, Dear JW, Park KB, Betensky R, Krolewski AS, Bonventre JV. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J. Am. Soc. Nephrol. 2014;25(10):2177-2186.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Scelo G, Muller DC, Riboli E, Johansson M, Cross AJ, Vineis P, Tsilidis KK, Brennan P, Boeing H, Peeters PHM, Vermeulen RCH, Overvad K, Bueno-de-Mesquita HB, Severi G, Perduca V, Kvaskoff M, Trichopoulou A, La Vecchia C, Karakatsani A, Palli D, Sieri S, Panico S, Weiderpass E, Sandanger TM, Nøst TH, Agudo A, Quirós JR, Rodríguez-Barranco M, Chirlaque MD, Key TJ, Khanna P, Bonventre JV, Sabbisetti VS, Bhatt RS. KIM-1 as a blood-based marker for early detection of kidney cancer: a prospective nested case-control study. Clin. Cancer Res. 2018;24(22):5594-5601.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Shalabi A, Abassi Z, Awad H, Halachmi S, Moskovitz B, Kluger Y, Nativ O. Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma. World J. Urol. 2013;31(6):1541-1545.

    Article  CAS  PubMed  Google Scholar 

  14. Waanders F, van Timmeren MM, Stegeman CA, Bakker SJ, van Goor H. Kidney injury molecule-1 in renal disease. J. Pathol. 2010;220(1):7-16.

    Article  CAS  PubMed  Google Scholar 

  15. Zhang PL, Mashni JW, Sabbisetti VS, Schworer CM, Wilson GD, Wolforth SC, Kernen KM, Seifman BD, Amin MB, Geddes TJ, Lin F, Bonventre JV, Hafron JM. Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma. Int. Urol. Nephrol. 2014;46(2):379-388.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. N. N. Blokhin National Medical Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russia

    N. E. Kushlinskii, E. S. Gershtein, D. S. Naberezhnov, S. D. Bezhanova, V. B. Matveev & I. S. Stilidi

  2. A. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation, Moscow, Russia

    M. A. Taipov & D. Yu. Pushkar’

Authors
  1. N. E. Kushlinskii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. S. Gershtein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. S. Naberezhnov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. A. Taipov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. D. Bezhanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Yu. Pushkar’
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. V. B. Matveev
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. I. S. Stilidi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. E. Kushlinskii.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 167, No. 3, pp. 364-368, March, 2019

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kushlinskii, N.E., Gershtein, E.S., Naberezhnov, D.S. et al. Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patients with Clear-Cell Carcinoma. Bull Exp Biol Med 167, 388–392 (2019). https://doi.org/10.1007/s10517-019-04533-w

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-019-04533-w

Key Words

Search

Navigation